Avenue Therapeutics announces first stage closing of acquisition agreement with InvaGen
Avenue Therapeutics, a Fortress company, announced completion of the first stage closing of the Acquisition Agreement with InvaGen Pharmaceuticals, a subsidiary of Cipla Limited. The Acquisition Agreement has been approved by a majority of Avenue’s stockholders. February 11, 2019
